OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Strong immune responses and protection of PcrV and OprF-I mRNA vaccine candidates against Pseudomonas aeruginosa
Xingyun Wang, Cong Liu, Nino Rcheulishvili, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 32
Xingyun Wang, Cong Liu, Nino Rcheulishvili, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
PEDV-spike-protein-expressing mRNA vaccine protects piglets against PEDV challenge
Yongxiang Zhao, Baochao Fan, Xu Song, et al.
mBio (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 23
Yongxiang Zhao, Baochao Fan, Xu Song, et al.
mBio (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 23
mRNA vaccines for infectious diseases — advances, challenges and opportunities
Norbert Pardi, Florian Krammer
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 13
Norbert Pardi, Florian Krammer
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 13
Advances in Development of Novel Therapeutic Strategies against Multi-Drug Resistant Pseudomonas aeruginosa
Changhong Yin, Md. Zahidul Alam, John T. Fallon, et al.
Antibiotics (2024) Vol. 13, Iss. 2, pp. 119-119
Open Access | Times Cited: 12
Changhong Yin, Md. Zahidul Alam, John T. Fallon, et al.
Antibiotics (2024) Vol. 13, Iss. 2, pp. 119-119
Open Access | Times Cited: 12
Advances in the design and delivery of RNA vaccines for infectious diseases
Abhijeet Lokras, Thomas Rønnemoes Bobak, Saahil Baghel, et al.
Advanced Drug Delivery Reviews (2024) Vol. 213, pp. 115419-115419
Open Access | Times Cited: 11
Abhijeet Lokras, Thomas Rønnemoes Bobak, Saahil Baghel, et al.
Advanced Drug Delivery Reviews (2024) Vol. 213, pp. 115419-115419
Open Access | Times Cited: 11
mRNA vaccine platforms to prevent bacterial infections
Carson Bergstrom, Nicholas O. Fischer, Jessica Z. Kubicek-Sutherland, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 6, pp. 524-526
Open Access | Times Cited: 8
Carson Bergstrom, Nicholas O. Fischer, Jessica Z. Kubicek-Sutherland, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 6, pp. 524-526
Open Access | Times Cited: 8
In silico designed novel multi-epitope mRNA vaccines against Brucella by targeting extracellular protein BtuB and LptD
Juan Shi, Yuejie Zhu, Zhengwei Yin, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Juan Shi, Yuejie Zhu, Zhengwei Yin, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Multivalent mRNA-DTP vaccines are immunogenic and provide protection from Bordetella pertussis challenge in mice
M. Allison Wolf, Joanne M. O’Hara, Graham J. Bitzer, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 8
M. Allison Wolf, Joanne M. O’Hara, Graham J. Bitzer, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 8
mRNA Technology in Modern Medicine: Review and Future Prospects
Heslley Machado Silva
Deleted Journal (2025) Vol. 2, pp. 1-1
Closed Access | Times Cited: 1
Heslley Machado Silva
Deleted Journal (2025) Vol. 2, pp. 1-1
Closed Access | Times Cited: 1
A review on Gaucher disease: therapeutic potential of β-glucocerebrosidase-targeted mRNA/saRNA approach
Shunping Feng, Nino Rcheulishvili, Xiaoming Jiang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 6, pp. 2111-2129
Open Access | Times Cited: 6
Shunping Feng, Nino Rcheulishvili, Xiaoming Jiang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 6, pp. 2111-2129
Open Access | Times Cited: 6
Enhanced protective efficacy of an OprF/PcrV bivalent DNA vaccine against Pseudomonas aeruginosa using a hydrogel delivery system
Yating Zhang, Linxia Tian, Xuan Zhao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116264-116264
Open Access | Times Cited: 5
Yating Zhang, Linxia Tian, Xuan Zhao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116264-116264
Open Access | Times Cited: 5
Vaccines and monoclonal antibodies to prevent healthcare-associated bacterial infections
Léo Sauvat, Paul O. Verhoeven, Julie Gagnaire, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 3
Closed Access | Times Cited: 5
Léo Sauvat, Paul O. Verhoeven, Julie Gagnaire, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 3
Closed Access | Times Cited: 5
One-pot ligation of multiple mRNA fragments on dsDNA splint advancing regional modification and translation
Yunfan Xu, Shu‐Tao Qi, Gongrui Zhang, et al.
Nucleic Acids Research (2025) Vol. 53, Iss. 1
Open Access
Yunfan Xu, Shu‐Tao Qi, Gongrui Zhang, et al.
Nucleic Acids Research (2025) Vol. 53, Iss. 1
Open Access
The (re)emergence of aerosol delivery: Treatment of pulmonary diseases and its clinical challenges
Rosy Ghanem, Raphaëlle Youf, Tanguy Haute, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 421-439
Open Access
Rosy Ghanem, Raphaëlle Youf, Tanguy Haute, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 421-439
Open Access
Multimeric, Multivalent Fusion Carrier Proteins for Site-Selective Glycoconjugate Vaccines Simultaneously Targeting Staphylococcus aureus and Pseudomonas aeruginosa
Charlotte Sorieul, Bartal Mikladal, Dung‐Yeh Wu, et al.
Chemical Science (2025)
Open Access
Charlotte Sorieul, Bartal Mikladal, Dung‐Yeh Wu, et al.
Chemical Science (2025)
Open Access
Pseudomonas aeruginosa Vaccine Development: Lessons, Challenges, and Future Innovations
Rebeca Santamarina-Fernández, Víctor Fuentes-Valverde, Alis Silva-Rodríguez, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2012-2012
Open Access
Rebeca Santamarina-Fernández, Víctor Fuentes-Valverde, Alis Silva-Rodríguez, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2012-2012
Open Access
Monosaccharide-Based Synthetic TLR4 Agonist Enhances Vaccine Efficacy against Pseudomonas aeruginosa Challenge
Maite Sainz-Mejías, Chaoying Ma, Yueran Hou, et al.
ACS Infectious Diseases (2025)
Open Access
Maite Sainz-Mejías, Chaoying Ma, Yueran Hou, et al.
ACS Infectious Diseases (2025)
Open Access
Bacterial carbonic anhydrase as a candidate vaccine target against Helicobacter pylori
György Miklós Buzás
Frontiers in Microbiology (2025) Vol. 16
Open Access
György Miklós Buzás
Frontiers in Microbiology (2025) Vol. 16
Open Access
Leveraging high-throughput screening technologies in targeted mRNA delivery
Yuchen Zhang, Zhifei Gao, Xiao Yang, et al.
Materials Today Bio (2024) Vol. 26, pp. 101101-101101
Open Access | Times Cited: 4
Yuchen Zhang, Zhifei Gao, Xiao Yang, et al.
Materials Today Bio (2024) Vol. 26, pp. 101101-101101
Open Access | Times Cited: 4
Pseudomonas aeruginosa in chronic lung disease: untangling the dysregulated host immune response
Rhea Nickerson, Christina S. Thornton, Brent Johnston, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Rhea Nickerson, Christina S. Thornton, Brent Johnston, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Immunostimulatory chimeric protein encapsulated in gelatin nanoparticles elicits protective immunity against Pseudomonas aeruginosa respiratory tract infection
Maryam Parvaei, Mehri Habibi, Shahla Shahbazi, et al.
International Journal of Biological Macromolecules (2024) Vol. 277, pp. 133964-133964
Closed Access | Times Cited: 3
Maryam Parvaei, Mehri Habibi, Shahla Shahbazi, et al.
International Journal of Biological Macromolecules (2024) Vol. 277, pp. 133964-133964
Closed Access | Times Cited: 3
Immunogenicity of a 30-valent M protein mRNA group A Streptococcus vaccine
Meredith B. Finn, Thomas A. Penfound, Sanaz Salehi, et al.
Vaccine (2024) Vol. 42, Iss. 22, pp. 126205-126205
Closed Access | Times Cited: 2
Meredith B. Finn, Thomas A. Penfound, Sanaz Salehi, et al.
Vaccine (2024) Vol. 42, Iss. 22, pp. 126205-126205
Closed Access | Times Cited: 2
Design, evaluation, and immune simulation of potentially universal multi-epitope mpox vaccine candidate: focus on DNA vaccine
Nino Rcheulishvili, Jiawei Mao, Dimitri Papukashvili, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 5
Nino Rcheulishvili, Jiawei Mao, Dimitri Papukashvili, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 5
Current Progress in the Development of mRNA Vaccines Against Bacterial Infections
А. Н. Хлебникова, Anna Kirshina, N. A. Zakharova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 13139-13139
Open Access | Times Cited: 1
А. Н. Хлебникова, Anna Kirshina, N. A. Zakharova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 13139-13139
Open Access | Times Cited: 1
Immunization with an mRNA DTP vaccine protects against pertussis in rats
Graham J. Bitzer, Nicholas FitzGerald, Megan A. DeJong, et al.
Infection and Immunity (2024) Vol. 92, Iss. 8
Open Access | Times Cited: 1
Graham J. Bitzer, Nicholas FitzGerald, Megan A. DeJong, et al.
Infection and Immunity (2024) Vol. 92, Iss. 8
Open Access | Times Cited: 1
Evolution of Vaccines Formulation to Tackle the Challenge of Anti-Microbial Resistant Pathogens
Francesco Tognetti, Massimiliano Biagini, Maxime Denis, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12054-12054
Open Access | Times Cited: 2
Francesco Tognetti, Massimiliano Biagini, Maxime Denis, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12054-12054
Open Access | Times Cited: 2
